These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 34412665)

  • 21. Selenium-containing thioredoxin reductase inhibitor ethaselen sensitizes non-small cell lung cancer to radiotherapy.
    Wang L; Fu JN; Wang JY; Jin CJ; Ren XY; Tan Q; Li J; Yin HW; Xiong K; Wang TY; Liu XM; Zeng HH
    Anticancer Drugs; 2011 Sep; 22(8):732-40. PubMed ID: 21562407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel thioredoxin reductase inhibitor inhibits cell growth and induces apoptosis in HL-60 and K562 cells.
    Peng ZF; Lan LX; Zhao F; Li J; Tan Q; Yin HW; Zeng HH
    J Zhejiang Univ Sci B; 2008 Jan; 9(1):16-21. PubMed ID: 18196608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mechanism of apoptosis induced by a novel thioredoxin reductase inhibitor in A549 cells: possible involvement of nuclear factor-kappaB-dependent pathway.
    Lan L; Zhao F; Wang Y; Zeng H
    Eur J Pharmacol; 2007 Jan; 555(2-3):83-92. PubMed ID: 17116300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethaselen: a novel organoselenium anticancer agent targeting thioredoxin reductase 1 reverses cisplatin resistance in drug-resistant K562 cells by inducing apoptosis.
    Ye SF; Yang Y; Wu L; Ma WW; Zeng HH
    J Zhejiang Univ Sci B; 2017 May; 18(5):373-382. PubMed ID: 28471109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity.
    Zheng X; Ma W; Sun R; Yin H; Lin F; Liu Y; Xu W; Zeng H
    Redox Biol; 2018 Apr; 14():237-249. PubMed ID: 28965082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel organoselenium compound induces cell cycle arrest and apoptosis in prostate cancer cell lines.
    Shi C; Yu L; Yang F; Yan J; Zeng H
    Biochem Biophys Res Commun; 2003 Sep; 309(3):578-83. PubMed ID: 12963029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel mechanism of ethaselen in poorly differentiated colorectal RKO cell growth inhibition: Simultaneous regulation of TrxR transcription, expression and enzyme activity.
    Yin H; Li J; Xiong K; Wang L; Wang T; Tan Q; Fu J; Ren X; Zeng H
    Differentiation; 2011 Jan; 81(1):49-56. PubMed ID: 20864247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inducing ubiquitination and degradation of TrxR1 protein by LW-216 promotes apoptosis in non-small cell lung cancer via triggering ROS production.
    Wang R; Zhong L; Wang T; Sun T; Yang J; Liu X; Wu Y; Guo Q; Gao Y; Zhao K
    Neoplasia; 2024 Jul; 53():101004. PubMed ID: 38733769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmented antitumor effects of combination therapy of cisplatin with ethaselen as a novel thioredoxin reductase inhibitor on human A549 cell in vivo.
    Tan Q; Li J; Yin HW; Wang LH; Tang WC; Zhao F; Liu XM; Zeng HH
    Invest New Drugs; 2010 Jun; 28(3):205-15. PubMed ID: 19271154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Costunolide specifically binds and inhibits thioredoxin reductase 1 to induce apoptosis in colon cancer.
    Zhuge W; Chen R; Vladimir K; Dong X; Zia K; Sun X; Dai X; Bao M; Shen X; Liang G
    Cancer Lett; 2018 Jan; 412():46-58. PubMed ID: 29037867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combining TRAIL and liquiritin exerts synergistic effects against human gastric cancer cells and xenograft in nude mice through potentiating apoptosis and ROS generation.
    Xie R; Gao CC; Yang XZ; Wu SN; Wang HG; Zhang JL; Yan W; Ma TH
    Biomed Pharmacother; 2017 Sep; 93():948-960. PubMed ID: 28715876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alantolactone promotes ER stress-mediated apoptosis by inhibition of TrxR1 in triple-negative breast cancer cell lines and in a mouse model.
    Yin C; Dai X; Huang X; Zhu W; Chen X; Zhou Q; Wang C; Zhao C; Zou P; Liang G; Rajamanickam V; Wang O; Zhang X; Cui R
    J Cell Mol Med; 2019 Mar; 23(3):2194-2206. PubMed ID: 30609207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation.
    Lu YX; Wu QN; Chen DL; Chen LZ; Wang ZX; Ren C; Mo HY; Chen Y; Sheng H; Wang YN; Wang Y; Lu JH; Wang DS; Zeng ZL; Wang F; Wang FH; Li YH; Ju HQ; Xu RH
    Theranostics; 2018; 8(5):1312-1326. PubMed ID: 29507622
    [No Abstract]   [Full Text] [Related]  

  • 34. Preparation of tri-block copolymer micelles loading novel organoselenium anticancer drug BBSKE and study of tissue distribution of copolymer micelles by imaging in vivo method.
    Liu M; Fu J; Li J; Wang L; Tan Q; Ren X; Peng Z; Zeng H
    Int J Pharm; 2010 May; 391(1-2):292-304. PubMed ID: 20211232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic antitumor effects of dasatinib and oxaliplatin in gastric cancer cells.
    Shi M; Lou B; Ji J; Shi H; Zhou C; Yu Y; Liu B; Zhu Z; Zhang J
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):35-44. PubMed ID: 23712327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selenocysteine induces apoptosis in human glioma cells: evidence for TrxR1-targeted inhibition and signaling crosstalk.
    Fan CD; Fu XY; Zhang ZY; Cao MZ; Sun JY; Yang MF; Fu XT; Zhao SJ; Shao LR; Zhang HF; Yang XY; Sun BL
    Sci Rep; 2017 Jul; 7(1):6465. PubMed ID: 28743999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Jolkinolide B targets thioredoxin and glutathione systems to induce ROS-mediated paraptosis and apoptosis in bladder cancer cells.
    Sang J; Li W; Diao HJ; Fan RZ; Huang JL; Gan L; Zou MF; Tang GH; Yin S
    Cancer Lett; 2021 Jul; 509():13-25. PubMed ID: 33836250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial ROS accumulation inhibiting JAK2/STAT3 pathway is a critical modulator of CYT997-induced autophagy and apoptosis in gastric cancer.
    Cao Y; Wang J; Tian H; Fu GH
    J Exp Clin Cancer Res; 2020 Jun; 39(1):119. PubMed ID: 32576206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ginsenoside Rg5 induces G2/M phase arrest, apoptosis and autophagy via regulating ROS-mediated MAPK pathways against human gastric cancer.
    Liu Y; Fan D
    Biochem Pharmacol; 2019 Oct; 168():285-304. PubMed ID: 31301277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose.
    Du Y; Zhang H; Lu J; Holmgren A
    J Biol Chem; 2012 Nov; 287(45):38210-9. PubMed ID: 22977247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.